Market Overview

UPDATE: Stifel Nicolaus Initiates IDEXX Laboratories at Hold on Valuation, Market Share Risk

Related IDXX
IDEXX Labs Sees One-Time Reduction In Operating Profit of $16M To $20M
Patterson Companies Q1 Fiscal Earnings Rise but Miss

Stifel Nicolaus initiated coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Hold rating.

Stifel Nicolaus commented, "IDEXX's dominance in what has proven to be a relatively resilient vet market is likely to continue. That said, we believe this is already reflected in the stock's premium valuation. In addition, our work uncovers some headwinds that may strengthen as we enter 2013, notably, future chemistry share losses and an unfavorable change in the distributor landscape."

IDEXX Laboratories closed at $93.89 on Wednesday.

Latest Ratings for IDXX

DateFirmActionFromTo
Jun 2014Canaccord GenuityUpgradesHoldBuy
Jan 2014Feltl & Co.DowngradesHoldSell
Apr 2013Canaccord GenuityMaintainsHold

View More Analyst Ratings for IDXX
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (IDXX)

Around the Web, We're Loving...

Get Benzinga's Newsletters